Nat Immunol. 2026 Jan 2. doi: 10.1038/s41590-025-02351-z. Online ahead of print. ABSTRACT Psoriatic disease initially affects the skin and later […]
Cleve Clin J Med. 2026 Jan 2;93(1):9-11. doi: 10.3949/ccjm.93a.24124. NO ABSTRACT PMID:41482463 | DOI:10.3949/ccjm.93a.24124
In Vivo. 2026 Jan-Feb;40(1):571-582. doi: 10.21873/invivo.14222. ABSTRACT BACKGROUND/AIM: Coexisting Sjögren’s syndrome (SS) and human leukocyte antigen-B27 (HLA-B27)-negative ankylosing spondylitis (AS)
In Vivo. 2026 Jan-Feb;40(1):561-570. doi: 10.21873/invivo.14221. ABSTRACT BACKGROUND/AIM: Rhupus syndrome, an overlap of rheumatoid arthritis (RA) and systemic lupus erythematosus
In Vivo. 2026 Jan-Feb;40(1):551-560. doi: 10.21873/invivo.14220. ABSTRACT BACKGROUND/AIM: Pulmonary arterial hypertension (PAH) is a significant and challenging complication for patients
Immunol Lett. 2025 Dec 31:107126. doi: 10.1016/j.imlet.2025.107126. Online ahead of print. ABSTRACT The lymphocyte-specific protein tyrosine kinase (LCK) is the
Respir Med. 2025 Dec 31:108629. doi: 10.1016/j.rmed.2025.108629. Online ahead of print. ABSTRACT PURPOSE: Anti-melanoma differentiation-associated gene 5 (MDA5) antibody is
Gene. 2025 Dec 31:149991. doi: 10.1016/j.gene.2025.149991. Online ahead of print. ABSTRACT BACKGROUND: Rheumatoid arthritis (RA) is a chronic autoimmune disease
Semin Arthritis Rheum. 2025 Dec 30;77:152905. doi: 10.1016/j.semarthrit.2025.152905. Online ahead of print. NO ABSTRACT PMID:41481969 | DOI:10.1016/j.semarthrit.2025.152905
Mangaluru, January 2, 2026: The Department of Rheumatology & Clinical Immunology at KMC Hospital Attavar, Mangaluru, will organise an Ankylosing …
… rheumatology OPD, KMC Hospital Attavar. The camp is being conducted under the theme ‘Stand Tall Again’ with the objective
Int Immunopharmacol. 2026 Jan 1;171:116137. doi: 10.1016/j.intimp.2025.116137. Online ahead of print. ABSTRACT OBJECTIVE: Interstitial lung disease (ILD) is the most
J Clin Rheumatol. 2025 Nov 13. doi: 10.1097/RHU.0000000000002292. Online ahead of print. ABSTRACT AIM: To analyze the clinical characteristics, treatment
Sci Adv. 2026 Jan 2;12(1):eaeb3720. doi: 10.1126/sciadv.aeb3720. Epub 2026 Jan 2. ABSTRACT Cross-electrophile coupling (XEC) has emerged as a powerful
Immunol Med. 2026 Jan 2:1-12. doi: 10.1080/25785826.2025.2604344. Online ahead of print. ABSTRACT Azathioprine (AZA) is an established treatment for rheumatic
Sjogrens is a hot area in drug development: “Sjogren’s Syndrome Pipeline Insight 2025” report provides comprehensi https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/02/2026
Comprehensive review of the management of knee osteoarthritis – topicals, analgesics, narcotics, intraarticular, metabo https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/02/2026 – 18:30
Inflammatory vs. Noninflammatory Pain https://t.co/ZZLMnT8IVO https://t.co/W0tVK75raN https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/02/2026 – 16:00 RheumNow Dr. John Cush Inflammatory vs. Noninflammatory Pain
The Regenerative Rheumatology Program focuses on conditions such as rheumatoid arthritis, osteoarthritis, lupus, ankylosing spondylitis, sports …
Mayo Clin Proc. 2026 Jan 2:S0025-6196(25)00616-0. doi: 10.1016/j.mayocp.2025.11.006. Online ahead of print. NO ABSTRACT PMID:41481215 | DOI:10.1016/j.mayocp.2025.11.006
Balkan Med J. 2026 Jan 2;43(1):3-14. doi: 10.4274/balkanmedj.galenos.2025.2025-11-133. ABSTRACT Familial Mediterranean Fever (FMF) is the first described and most prevalent
ARP Rheumatol. 2025 Oct-Dec;4(4):300-304. ABSTRACT Immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICI) are becoming more frequent with
ARP Rheumatol. 2025 Oct-Dec;4(4):294-299. ABSTRACT OBJECTIVE: This study aimed to evaluate subclinical myocardial involvement in asymptomatic juvenile systemic sclerosis (JSSc)
ARP Rheumatol. 2025 Oct-Dec;4(4):285-293. ABSTRACT AIMS: Methotrexate (MTX) is a basic therapy for juvenile idiopathic arthritis (JIA). MTX intolerance can
ARP Rheumatol. 2025 Oct-Dec;4(4):276-283. ABSTRACT INTRODUCTION: Apart from exocrine glands involvement with sicca symptoms, several extra-glandular manifestations can occur in
ARP Rheumatol. 2025 Oct-Dec;4(4):267-275. ABSTRACT OBJECTIVES: To assess adverse events (AE) associated with first-line therapies for rheumatoid arthritis (RA) in
ARP Rheumatol. 2025 Oct-Dec;4(4):264-266. NO ABSTRACT PMID:41480881
